https://www.selleckchem.com/pr....oducts/gilteritinib-
Advances in systemic cancer therapies have improved survival for patients with metastatic carcinoma; however, it is unknown whether these advances have translated to improved survival for patients with appendicular metastatic bone disease (A-MBD) after orthopedic interventions. We conducted a study to evaluate the trend in overall survival for patients who underwent orthopedic surgery for A-MBD between 1968 and 2018. A systematic search of Embase and Medline to identify studies published since 1968 evaluating patients treat
Like
Comment
Share
